Ron Gutman at the National Public Radio

Ron Gutman is an inventor, an investor, a serial technology and healthcare entrepreneur and a Stanford University adjunct Professor. His early career was in biochemistry. He co-invented the first and second generation of the polymerase chain reaction, which has been used in developing some major pharmaceutical drugs and procedures. This device is now dubbed “The Tool of Life.” A lot has changed since Ron started his own Life Extension Technologies business. 

 

Partly out of frustration with what he had to deal with at work, healthcare expert Ron Gutman began tinkering to transform work into his actual life mission. As a result, he developed a series of evolving medical tools used today by people around the globe, including doctors, veterinarians and even dentists who can no longer ignore complementary medicine as they have done for centuries.

 

 Ron Gutman Achievements:

 

Over the years, he has developed a portfolio of patents with major companies, including Genentech and Novartis; he currently holds over 50 patents and is working on several additional inventions. His patents include the patent filing on a comprehensive blood test that accurately measures many disease markers simultaneously.

 

Ron Gutman´s most recent invention can help detect cancer before it is possible to cure such a deadly disease. He holds over 40 patents and has been featured in numerous publications and media, including Forbes, and The Wall Street Journal, from which he was a weekly columnist for years; National Public Radio; Business Week and Stanford University’s alumni magazine. 

 

The healthcare expert has also been featured in numerous television interviews, including the Jenny Jones Show, the Ted Koppel Show, ABC News Nightline, The CBS Evening News with Dan Rather, and others. Ron Gutman has helped over 30,000 people in 120 countries around the globe improve their health and extend their lives. He is a self-made Entrepreneur, having founded or co-founded over 20 companies, including Veridex Diagnostics and R&D (acquired by Johnson & Johnson) and Life Extension Technologies, Inc.